REVA to Present at Cowen and Company 38th Annual Health Care Conference
SAN DIEGO, March 06, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that its Chief Financial Officer, Ms. Brandi Roberts, is scheduled to present at the Cowen and Company 38th Annual Health Care Conference on Wednesday, March 14, 2018 at 8:40 a.m. US EST. The conference is being held at the Boston Marriott Copley Place in Boston, MA.
The presentation materials delivered at the conference will be available in the Investor Relations section of REVA’s website at www.revamedical.com on the day of the presentation.
About REVA Medical
REVA Medical is a medical device company focused on the development and commercialization of bioresorbable polymer technologies for vascular applications. The Company’s lead products are the Fantom and Fantom Encore bioresorbable vascular scaffolds for the treatment of coronary artery disease. REVA is located in San Diego, California, USA and employs over 50 people in the U.S. and Europe.
Fantom and Fantom Encore are trademarks of REVA Medical, Inc.
| United States | Australia | Australia | |
| Investor & Media Enquiries: | Investor Enquiries: | Media Enquiries: | |
| REVA Medical, Inc. | Inteq Limited | Buchan Consulting | |
| Brandi Roberts | Kim Jacobs | Rebecca Wilson | |
| Chief Financial Officer | +61 438 217 279 | +61 3 9866 4722 | |
| +1 858-966-3003 | Andrew Cohen | ||
| Cheryl Liberatore | +61 408 333 452 | ||
| Director, Communications | |||
| +1 858-966-3045 | |||
| ir@revamedical.com | |||
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
